Averna Therapeutics
Genomic Medicines that Insert Therapeutic Genes into Safe Harbors Within the DNA
Startup · IsraelAverna Therapeutics is a Ness Ziona-based startup in the Health Tech & Life Sciences sector, established in 2022. Genomic Medicines that Insert Therapeutic Genes into Safe Harbors Within the DNA. The company has raised a total of $82M across 1 funding round, currently at the A stage. Key investors include Delos Capital, Novartis Venture Fund, Insight Partners, among 10 total investors. The company has 51-200 employees. Core technologies: Biologicals, Genes.
With $82M in total funding, Averna Therapeutics is a A-stage company operating in Health Tech & Life Sciences. The company follows a B2B/B2C business model. Product stage: Released.
- StageA
- ProductReleased
- ModelB2B, B2C
- Employees51-200
- HQNess Ziona
- DistrictCenter District
- Last Round$82M
- Delos CapitalLead
- Novartis Venture FundLead
- Insight Partners
10 investors total
3 articles covered by sources including en.globes.co.il,
www.prnewswire.com.
What does Averna Therapeutics do?
Averna Therapeutics is a biotechnology company specializing in the development of genomic medicines aimed at treating a wide array of diseases, including genetic disorders, cancer, and autoimmune conditions. The company's proprietary technology focuses on inserting therapeutic genetic instructions into specific "safe harbor" regions of the genome. These regions are selected to allow stable gene integration without disrupting normal cellular functions. By encoding their medicines in RNA, Averna utilizes validated, non-viral delivery platforms that are designed to be safe, efficient, scalable, and cost-effective. This approach also permits redosing with the intent to achieve curative outcomes.
How much funding has Averna Therapeutics raised?
Averna Therapeutics has raised $82M in total funding across 1 rounds. The company is currently at the A stage. Key investors include Delos Capital, Novartis Venture Fund, Insight Partners.
What sector is Averna Therapeutics in?
Averna Therapeutics operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Genes. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is Averna Therapeutics located?
Averna Therapeutics is based in Ilan Ramon St, Ness Ziona, Israel, Center District.